Table 1 Result of blood and urine tests performed before R-CHOP therapy
Parameter | Value | Unit | Reference value | Parameter | Value | Unit | Reference value | Parameter | Value | Unit | Reference value |
|---|---|---|---|---|---|---|---|---|---|---|---|
Blood cell count | Biochemistry | Immunology | |||||||||
WBC | 4720 | × 103/μL |  | TP | 9.0 | mg/dL | 6.5–8.2 | CRP | 0.79 | mg/dL | < 0.30 |
St | 0 | % | 0.0–19.0 | Alb | 3.6 | mg/dL | 3.7–5.5 | IgG | 2532 | mg/dL | 820–1740 |
Seg | 89 | % | 27.0–72.0 | α1 | 3.6 | % | 1.7–2.9 | IgA | 457 | mg/dL | 90–4000 |
Ly | 6 | % | 18.0–50.0 | α2 | 10.5 | % | 5.7–9.5 | IgM | 96 | mg/dL | 31–200 |
Mo | 5 | % | 1.0–8.0 | β | 10.0 | % | 7.2–11.1 | HBsAb | (−) |  | (−) |
Eo | 0 | % | 0.0–7.0 | γ | 29.5 | % | 10.2–20.4 | HBcAb | (−) |  | (−) |
Ba | 0 | % | 0.0–2.0 | BUN | 13 | mg/ dl | 8.0–20.0 | HBV-DNA | (−) |  | (−) |
RBC | 5 | ×106/μL | 4.38–5.77 | Cre | 1 | mg/ dl | 0.65–1.09 | HCV Ab | (+) |  | (−) |
Hb | 15 | g/dL | 13.6–18.3 | T-bil | 0.4 | mg/dL | 0.3–1.2 | HCV-RNA | 2.0 | LIU/ mL | (−) |
Ht |  | % | 40.4–51.9 | D-bil | 0.1 | mg/dL | < 0.4 | HCV serotype | Group2 |  | (−) |
Plt | 295 | ×103/μL | 14.0–37.9 | AST | 23 | U/L | 10–40 | HIV Ab | (−) |  | (−) |
|  |  |  |  | ALT | 19 | U/L | 5–45 | HTLV-1 Ab | (−) |  | (−) |
Coagulation | LDH | 211 | U/L | 120–245 |  |  |  |  | |||
PT | 12 | sec | 10.0–13.0 | ALP | 238 | U/L | 104–338 | Tumor Marker | |||
PT% | 99 | % | 80.0–120.0 | γ-GTP | 104 | U/L | < 79 | β2MG | 2.5 | mg/ L | 0.9–1.9 |
PT-INR | 1.01 | ratio | 0.90–1.13 | ChE | 305 | U/L | 245–495 | sIL-2R | 1753 | U/ mL |  |
APTT | 28 | sec | 26.0–38.0 | CPK | 53 | U/L | 50–230 | SP-D | 169.3 | ng/ mL | < 110.0 |
Fib | 304 | mg/dL | 170–410 |  |  |  |  |  |  |  |  |